What the company does
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, …
What the weekly tape is saying
GSK closed the latest completed week at 19,890 ARS. The 4-week return is 8.0% and the 12-week return is 4.8%. Trend Signal is inactive, Market Dynamics is -0.98. Setup signature: Risk-first tape with a 39/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 19,643 ARS
- Vs Trend Line
- 1.3%
- Fair Value
- 12,762 ARS
- Vs Fair Value
- 55.9%
- 52W High
- 22,760 ARS
- 52W Low
- 11,150 ARS
- Drawdown
- -12.6%
- Range Position
- 75.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 47
- 52W Active Breadth
- 90.4%
- Sector Scope
- AR Healthcare
- Sector Rank
- 3 of 20
- Sector Percentile
- 89.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AR Healthcare
- Tracked Peers
- 20
- 4W Rank
- 5 of 20
- Avg 1W
- -0.5%
- Avg 4W
- 5.2%
- Trend Breadth
- 25.0%
- Positive MD
- 20.0%
AR Drug Manufacturers - General
- Tracked Peers
- 13
- 4W Rank
- 4 of 13
- Avg 1W
- -0.6%
- Avg 4W
- 4.9%
- Trend Breadth
- 38.5%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.98
- 4W MD Change
- 5.4%
- Relative Strength
- -12.03
- 4W RS Change
- -780.7%
- Expectation
- Positive
- Probability
- 57.87%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.3K
- 13W Average
- 2.3K
- 52W Average
- 4.1K
- Vs 13W
- 0.5x
- Vs 52W
- 0.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.4%
- 52W Volatility
- 4.5%
- Upside Weeks
- 29
- Downside Weeks
- 22
- Downside Breadth
- 42.3%
- Avg Gain / Loss
- 4.2% / -3.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- BUE
- Country
- AR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- ARS
- Market Cap
- 147630.6B
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Market Dynamics is negative, which weakens the current setup.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 19,890 ARS | 1.9% | 19,643 ARS | 12,762 ARS | -0.98 | -12.03 | 1.3K | Off |
| 5 Jun 2026 | 19,510 ARS | 3.7% | 19,568 ARS | 12,663 ARS | -1.10 | -6.16 | 2.5K | Off |
| 29 May 2026 | 18,810 ARS | -1.3% | 19,488 ARS | 12,566 ARS | -1.15 | -11.71 | 4.2K | Off |
| 22 May 2026 | 19,050 ARS | 3.5% | 19,448 ARS | 12,472 ARS | -1.18 | -0.37 | 848 | Off |
| 15 May 2026 | 18,410 ARS | -1.8% | 19,379 ARS | 12,377 ARS | -1.03 | 1.77 | 2.3K | Off |
| 8 May 2026 | 18,740 ARS | -4.4% | 19,329 ARS | 12,287 ARS | -0.86 | 1.89 | 3.4K | On |
| 1 May 2026 | 19,610 ARS | -3.4% | 19,240 ARS | 12,195 ARS | -0.70 | 4.76 | 2.6K | On |
| 24 Apr 2026 | 20,310 ARS | -4.3% | 19,134 ARS | 12,096 ARS | -0.57 | 8.61 | 1.6K | On |
| 17 Apr 2026 | 21,220 ARS | -1.0% | 18,944 ARS | 11,992 ARS | -0.62 | 12.26 | 2.0K | On |
| 10 Apr 2026 | 21,430 ARS | 2.9% | 18,767 ARS | 11,883 ARS | -0.80 | 10.06 | 1.2K | On |
| 3 Apr 2026 | 20,830 ARS | 4.9% | 18,556 ARS | 11,770 ARS | -0.91 | 7.61 | 4.5K | On |
| 27 Mar 2026 | 19,850 ARS | 4.6% | 18,326 ARS | 11,661 ARS | -0.84 | 10.48 | 2.9K | On |
| 20 Mar 2026 | 18,980 ARS | -3.2% | 18,110 ARS | 11,557 ARS | -0.45 | 8.88 | 897 | On |
| 13 Mar 2026 | 19,610 ARS | -2.9% | 17,924 ARS | 11,457 ARS | 0.02 | 16.64 | 810 | On |